Navigation Links
NCCN and SEHA Collaborate to Improve Cancer Care
Date:1/14/2009

NCCN, in collaboration with the Abu Dhabi Health Services Company (SEHA), announce The Second Annual Middle East and North Africa NCCN Guidelines Congress scheduled for April 23 - 26, 2009 in Abu Dhabi, United Arab Emirates (UAE). The program will present the latest developments in treating common cancers and generate discussions around developing regional guidelines.

FORT WASHINGTON, Pa., Jan. 14 /PRNewswire-USNewswire/ -- The National Comprehensive Cancer Network (NCCN) is pleased to announce that it will hold the Second Annual Middle East and Northern Africa NCCN Clinical Guidelines Congress in Abu Dhabi, United Arab Emirates (UAE) from April 23 - 26, 2009. The Congress will be a collaborative educational effort with the Abu Dhabi Health Services Company (SEHA) to improve the safety, effectiveness, and quality of cancer care in the Middle East and North Africa.

SEHA is a public joint stock company that owns and operates Abu Dhabi's 12 public hospitals and 40 ambulatory clinics. NCCN and SEHA will be supported by the Health Authority - Abu Dhabi (HA-AD), the government regulatory body which is in charge of licensing and healthcare policy in Abu Dhabi.

"We are grateful for the invitation and opportunity to collaborate with our colleagues in the Middle East and North Africa," says William T. McGivney, Ph.D., Chief Executive Officer, NCCN. "It is critical that the scientific evidence that is the basis for cancer care guidelines be discussed and implemented by experts across the globe in order to improve outcomes for patients whom we serve."

The NCCN Guidelines Congress brings together leading clinicians from the Middle East, Northern Africa and the United States. Experts from NCCN Member Institutions will present the latest recommendations and updates from the NCCN Guidelines. These guidelines are widely recognized and applied in the United States as the standard for clinical policy in oncology. Thought leaders from the Middle East and North Africa will provide their perspectives on the management of specific diagnoses and discuss issues related to differences across patient subpopulations, including the availability of health care technology such as drugs, devices, and procedures.

"SEHA is committed to bringing world class healthcare to the residents of Abu Dhabi," says Saif Bader Al Qubaisi, Managing Director, SEHA. "We want to assure the availability of evidence-based best practice in cancer treatment and innovative technology for applications in cancer care that are based upon sound clinical results and the expert judgment of leading clinicians. We are pleased to assemble leaders from across our region to bring better cancer care to patients."

The Congress will focus on the appropriate management of patients diagnosed with breast, prostate, colon, non small-cell lung, ovarian, and hepatobiliary cancers, as well as non Hodgkin's lymphomas and supportive care issues.

Since 2003, NCCN has offered the NCCN International Guidelines Symposia Series to communicate the NCCN Guidelines in a direct and interactive way around the world to local oncologists and other clinical professionals.

About SEHA

SEHA is health in Arabic. The Abu Dhabi Health Services Company - whose corporate identity is SEHA - is an independent, public joint stock company created to manage and develop the curative activities of the public hospitals and clinics of the Emirate of Abu Dhabi. SEHA is committed to providing quality, cost effective healthcare on par with international standards measured through accessibility, affordability, choice and satisfaction. SEHA owns and operates 12 hospital facilities, 2,644 licensed beds, and more than 40 Ambulatory and Primary Healthcare Clinics. SEHA is one of the largest employers in the Middle East with more than 16,500 doctors, nurses and other clinical staff and administration employed. For more information, visit www.seha.ae or contact James S Ferrier at jferrier@seha.ae or Salama Al Mazrouei at smazrouei@seha.ae.

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives.

The NCCN Member Institutions are: City of Hope, Los Angeles, CA; Dana-Farber/Brigham and Women's Cancer Center / Massachusetts General Hospital Cancer Center, Boston, MA; Duke Comprehensive Cancer Center, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; Arthur G. James Cancer Hospital & Richard J. Solove Research Institute at The Ohio State University, Columbus, OH; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Memorial Sloan-Kettering Cancer Center, New York, NY; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children's Research Hospital/University of Tennessee Cancer Institute, Memphis, TN; Stanford Comprehensive Cancer Center, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; UNMC Eppley Cancer Center at The Nebraska Medical Center, Omaha, NE; The University of Texas M. D. Anderson Cancer Center, Houston, TX; and Vanderbilt-Ingram Cancer Center, Nashville, TN. For more information on NCCN, please visit www.nccn.org.


'/>"/>
SOURCE National Comprehensive Cancer Network
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Recovery Resources Collaborates with Two Nonprofit Agencies for Children of Alcoholics Outreach Program
2. MU researchers to collaborate on $20 million project
3. AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks with ADHD Medications
4. The American Pain Foundation (APF) and The HealthCentral Network Collaborate to Develop Enhanced Internet Resources for People with Pain
5. EHRVA Members Collaborate to Demonstrate Interoperability Success at NCHICA
6. Rosecrance and Chicagos Department of Environment Collaborate to Help Families Dispose of Unwanted Medicines and Drugs
7. CIDM Collaborates With World Congress to Advance Dialog on Online Provider Networks at WHIT 3.0
8. Free Access to Literature Data on Chagas Disease Offered Online: Collaborative Drug Discovery, Inc. provides Neglected Disease researchers with archive mine and collaborate access to small molecule bioactivity SAR data on parasitic disease
9. SAIC to Collaborate with UK Biometrics Institute
10. General Motors, Virginia Tech scientists collaborate to advance neuroinformatics
11. ThalesNano Inc. and the Christian Doppler Laboratory for Microwave Chemistry in Graz, Austria Collaborate on Flow Chemistry Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... March 22, 2017 , ... ... California and Nevada and LABS, Inc., announced the future opening of a CLIA ... screening and serology testing used to determine the suitability of potential organ ...
(Date:3/22/2017)... ... ... Wash Tower Ltd. has released a series of six viral poo-related teaser ... standalone constant pressure bidet. , The videos in the series titled "The Adventures of ... well as on its social media pages. , Each video stars Arthur the Butler ...
(Date:3/22/2017)... ... 2017 , ... The Rett Syndrome Research Trust (RSRT) announced ... afflicts 350,000 individuals worldwide. Rett Syndrome is caused by alterations in a ... Following a normal infancy, Rett Syndrome takes effect in toddlerhood depriving children ...
(Date:3/22/2017)... ... 2017 , ... Drs. Jennifer Houck, Lauren Smith, Heather Johnson and the India ... need of skilled pediatric dentistry in Rock Hill, SC, without a referral. ... treatments, including cavities, sealants and fluoride applications, in a comfortable and fun environment. , ...
(Date:3/22/2017)... , ... March 22, 2017 , ... ... entered into a research collaboration to translate advances in basic neuroscience at the ... Blythedale and beyond. The collaboration seeks to improve movement, vision, and cognition impaired by ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... solutions, today reported financial and operational results for ... 31, 2016. 2016 Highlights ... compared to the full year 2015  ... year  Direct-to-consumer model launched in ...
(Date:3/22/2017)... today announced the appointment of Martyn Coombs as Chief ... ImaginAb, said "At ImaginAb we have exciting science and technology. Martyn ... business, particularly in commercializing and making step changes in the value ... our potential." ... Coombs is a recognized industry leader in nuclear medicine and imaging. ...
(Date:3/22/2017)... -- Ablation is the minimally invasive therapeutic tissue excision ... from cancerous or diseased tissue removal, to the ... fibrillation and others. The growing adoption of minimally ... and improvise existing ablation technologies for better patient ... is expected to grow at high single digit ...
Breaking Medicine Technology: